E-PaperBoehringer Ingelheim News
Lupin in pact with Boehringer Ingelheim to market diabetic drug
As per the agreement, Lupin will market and sell empagliflozin under a separate brand name Gibtulio which will be promoted by Lupin's specialty field force
2 min read14 Oct 2016Boehringer-Gennova: Battle over approval to stroke medicine continues at Delhi HC
A judge directs that legal battle on the heart drug tenectaplase be heard by a bench headed by Delhi HC chief justice, before whom another similar matter is pending
1 min read5 Sep 2016Lupin in pact with Germany’s Boehringer to sell diabetes drugs in India
Lupin will market and sell linagliptin, a blood glucose inhibitor for type II diabetes, under a separate brand name Ondero and Ondero Met
1 min read14 Oct 2015Germany’s Boehringer loses India patent on lung drug to Cipla
Cipla had filed an opposition to Boehringer’s patent on Spiriva in 2013, claiming the drug did not constitute an invention under India’s patent laws
1 min read10 Mar 2015Insulin pen HumaPen Savvio launched in India
The insulin pen for diabetes, developed by Eli Lilly and Boehringer Ingelheim, has a shelf life of six years
1 min read21 Jan 2014Boehringer-Lilly alliance likely to set trend
Boehringer-Lilly alliance likely to set trend
2 min read14 Jun 2012Partnership is better alternative to acquisition
Partnership is better alternative to acquisition
5 min read15 Mar 2012Glenmark unit gets tentative FDA nod for 2 drugs
Glenmark unit gets tentative FDA nod for 2 drugs
1 min read24 Dec 2009Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared